Concepts (284)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pneumococcal Infections | 28 | 2022 | 497 | 5.780 |
Why?
|
Carrier State | 29 | 2021 | 518 | 5.770 |
Why?
|
Streptococcus pneumoniae | 29 | 2021 | 714 | 5.680 |
Why?
|
Israel | 57 | 2023 | 796 | 4.730 |
Why?
|
Pneumococcal Vaccines | 21 | 2022 | 391 | 4.620 |
Why?
|
Staphylococcus aureus | 19 | 2020 | 1451 | 3.630 |
Why?
|
Staphylococcal Infections | 21 | 2020 | 1400 | 3.230 |
Why?
|
Nasopharynx | 15 | 2019 | 379 | 2.330 |
Why?
|
Health Personnel | 14 | 2023 | 3218 | 1.770 |
Why?
|
Vaccines, Conjugate | 10 | 2022 | 333 | 1.640 |
Why?
|
Antibiosis | 5 | 2018 | 45 | 1.620 |
Why?
|
Antibodies, Viral | 21 | 2023 | 3176 | 1.500 |
Why?
|
Community-Acquired Infections | 8 | 2019 | 465 | 1.390 |
Why?
|
Vaccination | 22 | 2024 | 3278 | 1.310 |
Why?
|
Antibodies, Neutralizing | 16 | 2023 | 1978 | 1.210 |
Why?
|
Vaccines | 6 | 2023 | 822 | 1.060 |
Why?
|
Influenza Vaccines | 2 | 2023 | 738 | 1.010 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 7 | 2018 | 687 | 1.000 |
Why?
|
Immunoglobulin G | 12 | 2023 | 4560 | 0.930 |
Why?
|
Fimbriae Proteins | 2 | 2016 | 134 | 0.890 |
Why?
|
Cross Infection | 10 | 2021 | 1416 | 0.880 |
Why?
|
Laundry Service, Hospital | 1 | 2021 | 2 | 0.830 |
Why?
|
Enterobacteriaceae Infections | 1 | 2023 | 187 | 0.820 |
Why?
|
Immunity, Herd | 3 | 2021 | 44 | 0.790 |
Why?
|
Meningitis, Pneumococcal | 2 | 2018 | 42 | 0.790 |
Why?
|
Asymptomatic Diseases | 2 | 2021 | 551 | 0.770 |
Why?
|
Methicillin Resistance | 6 | 2018 | 198 | 0.760 |
Why?
|
Orthomyxoviridae | 1 | 2021 | 156 | 0.730 |
Why?
|
Influenza, Human | 2 | 2021 | 1479 | 0.730 |
Why?
|
Disease Outbreaks | 6 | 2021 | 1772 | 0.700 |
Why?
|
Serratia Infections | 1 | 2018 | 7 | 0.670 |
Why?
|
Infectious Disease Transmission, Vertical | 2 | 2019 | 1320 | 0.670 |
Why?
|
Immunization, Secondary | 5 | 2023 | 340 | 0.650 |
Why?
|
Serratia marcescens | 1 | 2018 | 45 | 0.650 |
Why?
|
Masks | 1 | 2020 | 197 | 0.640 |
Why?
|
Molecular Typing | 3 | 2016 | 106 | 0.640 |
Why?
|
Immunization Programs | 3 | 2016 | 260 | 0.610 |
Why?
|
Pneumonia, Pneumococcal | 1 | 2018 | 127 | 0.600 |
Why?
|
Equipment Contamination | 1 | 2018 | 185 | 0.590 |
Why?
|
Hydrogen Peroxide | 4 | 2016 | 731 | 0.570 |
Why?
|
Infant | 34 | 2022 | 35136 | 0.540 |
Why?
|
Schools | 2 | 2022 | 1433 | 0.530 |
Why?
|
Humans | 115 | 2024 | 744343 | 0.520 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 547 | 0.510 |
Why?
|
Infection Control | 6 | 2021 | 966 | 0.480 |
Why?
|
Serotyping | 6 | 2022 | 338 | 0.450 |
Why?
|
Child, Preschool | 27 | 2022 | 41006 | 0.420 |
Why?
|
Adult | 44 | 2023 | 214055 | 0.420 |
Why?
|
Anti-Bacterial Agents | 15 | 2019 | 7181 | 0.410 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 5 | 2018 | 143 | 0.410 |
Why?
|
Interleukin-17 | 1 | 2018 | 899 | 0.410 |
Why?
|
Pyruvate Oxidase | 2 | 2007 | 7 | 0.380 |
Why?
|
Population Surveillance | 4 | 2018 | 2616 | 0.380 |
Why?
|
Female | 62 | 2024 | 380194 | 0.380 |
Why?
|
Male | 56 | 2023 | 350118 | 0.380 |
Why?
|
Microbial Viability | 2 | 2009 | 234 | 0.360 |
Why?
|
Contact Tracing | 2 | 2022 | 273 | 0.350 |
Why?
|
Nose | 3 | 2020 | 509 | 0.340 |
Why?
|
Middle Aged | 38 | 2023 | 213383 | 0.340 |
Why?
|
Rectum | 4 | 2019 | 904 | 0.330 |
Why?
|
Fimbriae, Bacterial | 1 | 2009 | 138 | 0.330 |
Why?
|
Prevalence | 9 | 2021 | 15226 | 0.320 |
Why?
|
Meningococcal Vaccines | 1 | 2008 | 95 | 0.310 |
Why?
|
Pandemics | 7 | 2022 | 8388 | 0.300 |
Why?
|
Infant, Newborn | 19 | 2024 | 25625 | 0.300 |
Why?
|
Prospective Studies | 19 | 2023 | 53288 | 0.290 |
Why?
|
Klebsiella pneumoniae | 2 | 2023 | 251 | 0.290 |
Why?
|
Microbial Sensitivity Tests | 8 | 2018 | 1877 | 0.270 |
Why?
|
Cross-Sectional Studies | 10 | 2024 | 25043 | 0.270 |
Why?
|
Haemophilus influenzae | 2 | 2016 | 171 | 0.270 |
Why?
|
Nasal Mucosa | 2 | 2019 | 373 | 0.270 |
Why?
|
Child | 21 | 2022 | 77709 | 0.270 |
Why?
|
Drug Resistance, Bacterial | 6 | 2019 | 1035 | 0.260 |
Why?
|
Triage | 3 | 2021 | 976 | 0.260 |
Why?
|
Intensive Care Units | 1 | 2018 | 3679 | 0.260 |
Why?
|
Umbilicus | 2 | 2017 | 41 | 0.250 |
Why?
|
Tuberculosis, Spinal | 1 | 2004 | 16 | 0.250 |
Why?
|
Young Adult | 19 | 2021 | 56430 | 0.250 |
Why?
|
Retropharyngeal Abscess | 1 | 2004 | 21 | 0.250 |
Why?
|
DNA, Bacterial | 4 | 2018 | 1465 | 0.240 |
Why?
|
Ear | 2 | 2017 | 173 | 0.240 |
Why?
|
Genotype | 4 | 2018 | 12951 | 0.240 |
Why?
|
Parents | 3 | 2020 | 3407 | 0.240 |
Why?
|
Aged | 25 | 2023 | 163280 | 0.240 |
Why?
|
Meningitis, Bacterial | 2 | 2017 | 218 | 0.230 |
Why?
|
Specimen Handling | 1 | 2008 | 694 | 0.230 |
Why?
|
Epidural Abscess | 1 | 2004 | 84 | 0.230 |
Why?
|
Primaquine | 2 | 2000 | 28 | 0.230 |
Why?
|
Adolescent | 22 | 2022 | 85781 | 0.230 |
Why?
|
Follow-Up Studies | 7 | 2023 | 39050 | 0.220 |
Why?
|
Penicillin Resistance | 1 | 2003 | 84 | 0.220 |
Why?
|
RNA, Viral | 2 | 2021 | 2902 | 0.220 |
Why?
|
Ceftriaxone | 2 | 2022 | 168 | 0.220 |
Why?
|
Enterobacteriaceae | 1 | 2023 | 169 | 0.210 |
Why?
|
Clostridium Infections | 2 | 2020 | 548 | 0.210 |
Why?
|
Vaccines, Synthetic | 2 | 2022 | 634 | 0.210 |
Why?
|
Fomites | 1 | 2021 | 13 | 0.210 |
Why?
|
Bacterial Proteins | 4 | 2023 | 3848 | 0.200 |
Why?
|
beta-Lactamases | 1 | 2023 | 306 | 0.200 |
Why?
|
Incidence | 9 | 2022 | 20947 | 0.200 |
Why?
|
Statistics as Topic | 1 | 2008 | 2373 | 0.200 |
Why?
|
Drug Prescriptions | 1 | 2011 | 1637 | 0.200 |
Why?
|
Bacteremia | 3 | 2017 | 962 | 0.200 |
Why?
|
Liver Transplantation | 2 | 2023 | 2119 | 0.200 |
Why?
|
Molecular Epidemiology | 2 | 2015 | 468 | 0.200 |
Why?
|
RNA, Messenger | 5 | 2022 | 13033 | 0.200 |
Why?
|
Boutonneuse Fever | 1 | 2000 | 1 | 0.200 |
Why?
|
Immunoglobulin A | 2 | 2021 | 992 | 0.190 |
Why?
|
Vagina | 2 | 2019 | 825 | 0.190 |
Why?
|
Cohort Studies | 7 | 2023 | 40561 | 0.190 |
Why?
|
Ships | 1 | 2020 | 61 | 0.190 |
Why?
|
Hospitals, Special | 1 | 2021 | 101 | 0.190 |
Why?
|
Glucosephosphate Dehydrogenase Deficiency | 1 | 2000 | 89 | 0.180 |
Why?
|
Streptococcal Infections | 1 | 2004 | 638 | 0.180 |
Why?
|
Aged, 80 and over | 15 | 2023 | 57776 | 0.180 |
Why?
|
Cluster Analysis | 3 | 2012 | 2715 | 0.180 |
Why?
|
Mass Vaccination | 1 | 2021 | 105 | 0.170 |
Why?
|
Intensive Care Units, Neonatal | 2 | 2006 | 780 | 0.170 |
Why?
|
Haemophilus Infections | 2 | 2016 | 95 | 0.170 |
Why?
|
Respiratory Tract Infections | 2 | 2016 | 961 | 0.160 |
Why?
|
Disease Reservoirs | 1 | 2018 | 131 | 0.160 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2021 | 253 | 0.160 |
Why?
|
Cervical Vertebrae | 1 | 2004 | 975 | 0.150 |
Why?
|
Drug Resistance, Multiple, Bacterial | 3 | 2018 | 567 | 0.150 |
Why?
|
Odds Ratio | 3 | 2018 | 9849 | 0.150 |
Why?
|
Family Characteristics | 1 | 2022 | 1000 | 0.150 |
Why?
|
Bayes Theorem | 2 | 2022 | 2309 | 0.150 |
Why?
|
Emergency Service, Hospital | 3 | 2021 | 7659 | 0.150 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2021 | 4751 | 0.140 |
Why?
|
Milk, Human | 1 | 2021 | 490 | 0.140 |
Why?
|
Sepsis | 3 | 2017 | 2593 | 0.140 |
Why?
|
Arabs | 2 | 2015 | 178 | 0.140 |
Why?
|
Bacterial Toxins | 2 | 2020 | 931 | 0.140 |
Why?
|
Medical Staff, Hospital | 1 | 2021 | 603 | 0.140 |
Why?
|
Viral Vaccines | 1 | 2022 | 636 | 0.140 |
Why?
|
Middle East | 2 | 2018 | 219 | 0.140 |
Why?
|
Immunocompromised Host | 1 | 2021 | 847 | 0.140 |
Why?
|
Antimalarials | 2 | 2000 | 905 | 0.140 |
Why?
|
Communicable Disease Control | 2 | 2020 | 857 | 0.130 |
Why?
|
Penicillins | 2 | 2022 | 380 | 0.130 |
Why?
|
Treatment Failure | 1 | 2021 | 2618 | 0.130 |
Why?
|
Leukocytes, Mononuclear | 2 | 2022 | 1836 | 0.130 |
Why?
|
Age Factors | 6 | 2022 | 18370 | 0.130 |
Why?
|
Anaphylaxis | 1 | 2021 | 746 | 0.120 |
Why?
|
Phylogeny | 1 | 2021 | 2803 | 0.120 |
Why?
|
Travel | 1 | 1999 | 788 | 0.120 |
Why?
|
Jews | 1 | 2015 | 385 | 0.110 |
Why?
|
Species Specificity | 1 | 2018 | 2478 | 0.110 |
Why?
|
Interleukins | 1 | 2018 | 791 | 0.110 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2017 | 2026 | 0.110 |
Why?
|
Longitudinal Studies | 5 | 2022 | 13989 | 0.110 |
Why?
|
Interleukin-10 | 1 | 2018 | 1200 | 0.110 |
Why?
|
History, 21st Century | 1 | 2018 | 1534 | 0.100 |
Why?
|
Immunity | 3 | 2022 | 1012 | 0.100 |
Why?
|
International Cooperation | 1 | 2018 | 1420 | 0.100 |
Why?
|
Case-Control Studies | 4 | 2021 | 21746 | 0.100 |
Why?
|
Escherichia coli | 1 | 2023 | 4217 | 0.100 |
Why?
|
Th17 Cells | 1 | 2018 | 766 | 0.100 |
Why?
|
Methicillin | 1 | 2011 | 59 | 0.100 |
Why?
|
Linear Models | 1 | 2021 | 5952 | 0.100 |
Why?
|
Mothers | 2 | 2020 | 2165 | 0.090 |
Why?
|
Pregnancy | 5 | 2024 | 29144 | 0.090 |
Why?
|
Poisson Distribution | 1 | 2011 | 513 | 0.090 |
Why?
|
Catalase | 2 | 2009 | 222 | 0.090 |
Why?
|
Malaria | 1 | 1999 | 1239 | 0.090 |
Why?
|
DNA Fingerprinting | 1 | 2009 | 112 | 0.090 |
Why?
|
Operon | 1 | 2010 | 363 | 0.090 |
Why?
|
Otitis Media | 2 | 2016 | 277 | 0.090 |
Why?
|
Carbapenems | 1 | 2010 | 118 | 0.090 |
Why?
|
Klebsiella Infections | 1 | 2010 | 138 | 0.080 |
Why?
|
Bacterial Typing Techniques | 1 | 2009 | 256 | 0.080 |
Why?
|
Culture | 1 | 2013 | 633 | 0.080 |
Why?
|
Neoplasms | 3 | 2022 | 21683 | 0.080 |
Why?
|
Drug Resistance, Microbial | 1 | 2011 | 862 | 0.080 |
Why?
|
Patient Acceptance of Health Care | 1 | 2021 | 3022 | 0.080 |
Why?
|
Sex Factors | 1 | 2021 | 10397 | 0.080 |
Why?
|
Attitude of Health Personnel | 1 | 2021 | 3843 | 0.080 |
Why?
|
Colony Count, Microbial | 1 | 2007 | 331 | 0.070 |
Why?
|
Risk Factors | 10 | 2019 | 72290 | 0.070 |
Why?
|
Virus Activation | 1 | 2009 | 319 | 0.070 |
Why?
|
Multivariate Analysis | 3 | 2023 | 12245 | 0.070 |
Why?
|
Child Day Care Centers | 2 | 2008 | 123 | 0.070 |
Why?
|
Retrospective Studies | 10 | 2024 | 77449 | 0.070 |
Why?
|
Bacteriophages | 1 | 2009 | 356 | 0.070 |
Why?
|
Fungemia | 1 | 2005 | 53 | 0.070 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10180 | 0.070 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 12959 | 0.070 |
Why?
|
Socioeconomic Factors | 2 | 2019 | 7785 | 0.070 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2007 | 712 | 0.060 |
Why?
|
Drug Utilization | 1 | 2011 | 1183 | 0.060 |
Why?
|
Candida | 1 | 2005 | 172 | 0.060 |
Why?
|
Body Mass Index | 1 | 2021 | 12720 | 0.060 |
Why?
|
Health Education | 1 | 2010 | 1056 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 3870 | 0.060 |
Why?
|
Health Policy | 1 | 2016 | 2661 | 0.060 |
Why?
|
Hospitalization | 3 | 2019 | 10262 | 0.050 |
Why?
|
Time Factors | 2 | 2021 | 40075 | 0.050 |
Why?
|
Secretory Component | 1 | 2022 | 16 | 0.050 |
Why?
|
Residence Characteristics | 2 | 2021 | 2050 | 0.050 |
Why?
|
Candida albicans | 1 | 2005 | 394 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 2022 | 248 | 0.050 |
Why?
|
Animals, Newborn | 1 | 2007 | 2726 | 0.050 |
Why?
|
Carnobacteriaceae | 1 | 2020 | 10 | 0.050 |
Why?
|
Age Distribution | 2 | 2005 | 2902 | 0.050 |
Why?
|
Streptococcus | 1 | 2020 | 197 | 0.050 |
Why?
|
Bacterial Shedding | 1 | 2020 | 10 | 0.050 |
Why?
|
Kidney Failure, Chronic | 1 | 2013 | 2538 | 0.050 |
Why?
|
Mefloquine | 1 | 1999 | 55 | 0.050 |
Why?
|
Environmental Microbiology | 1 | 2020 | 46 | 0.040 |
Why?
|
Seroepidemiologic Studies | 1 | 2021 | 401 | 0.040 |
Why?
|
Genetic Variation | 1 | 2015 | 6544 | 0.040 |
Why?
|
Antibodies, Bacterial | 2 | 2008 | 1470 | 0.040 |
Why?
|
Lactation | 1 | 2021 | 412 | 0.040 |
Why?
|
Risk Assessment | 3 | 2021 | 23338 | 0.040 |
Why?
|
Asymptomatic Infections | 1 | 2019 | 128 | 0.040 |
Why?
|
Doxycycline | 1 | 1999 | 326 | 0.040 |
Why?
|
Public Health | 1 | 2011 | 2603 | 0.040 |
Why?
|
Malaria, Vivax | 1 | 2000 | 173 | 0.040 |
Why?
|
Plasmodium vivax | 1 | 1999 | 208 | 0.040 |
Why?
|
Penicillin-Binding Proteins | 1 | 2018 | 137 | 0.040 |
Why?
|
Sex Distribution | 1 | 2003 | 2297 | 0.040 |
Why?
|
Metagenomics | 1 | 2020 | 428 | 0.040 |
Why?
|
Probability | 1 | 2003 | 2505 | 0.040 |
Why?
|
Massachusetts | 1 | 2010 | 8663 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2015 | 5319 | 0.040 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2020 | 954 | 0.040 |
Why?
|
Leukocidins | 1 | 2016 | 17 | 0.040 |
Why?
|
Confidence Intervals | 1 | 2003 | 2971 | 0.040 |
Why?
|
Immunity, Humoral | 1 | 2021 | 598 | 0.040 |
Why?
|
Exotoxins | 1 | 2016 | 119 | 0.040 |
Why?
|
Workflow | 1 | 2021 | 847 | 0.030 |
Why?
|
Pediatrics | 1 | 2011 | 3475 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 1 | 2007 | 8301 | 0.030 |
Why?
|
Antitubercular Agents | 1 | 2004 | 1320 | 0.030 |
Why?
|
Hydroxychloroquine | 1 | 1999 | 412 | 0.030 |
Why?
|
Oropharynx | 1 | 2016 | 127 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2010 | 3923 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 2020 | 1537 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2021 | 783 | 0.030 |
Why?
|
Immunization | 1 | 1999 | 1256 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 738 | 0.030 |
Why?
|
Europe | 1 | 2021 | 3339 | 0.030 |
Why?
|
Feces | 1 | 2020 | 1401 | 0.030 |
Why?
|
United States | 1 | 2021 | 69872 | 0.030 |
Why?
|
Morbidity | 1 | 2019 | 1769 | 0.030 |
Why?
|
Hypersensitivity | 1 | 2021 | 1102 | 0.030 |
Why?
|
Placenta | 1 | 2021 | 1698 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2021 | 6171 | 0.030 |
Why?
|
Apoptosis | 1 | 2007 | 9727 | 0.020 |
Why?
|
Rats | 1 | 2007 | 24260 | 0.020 |
Why?
|
HIV Infections | 1 | 2017 | 16718 | 0.020 |
Why?
|
Plasmodium falciparum | 1 | 1999 | 1732 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14722 | 0.020 |
Why?
|
Intention to Treat Analysis | 1 | 2010 | 426 | 0.020 |
Why?
|
Lysogeny | 1 | 2009 | 67 | 0.020 |
Why?
|
Genes, Bacterial | 1 | 2012 | 1079 | 0.020 |
Why?
|
Mitomycin | 1 | 2009 | 259 | 0.020 |
Why?
|
Inpatients | 1 | 2020 | 2518 | 0.020 |
Why?
|
Bacterial Capsules | 1 | 2008 | 251 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2016 | 63114 | 0.020 |
Why?
|
Hospitals | 1 | 2019 | 3952 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 2010 | 1179 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2009 | 1341 | 0.020 |
Why?
|
Recurrence | 1 | 2016 | 8340 | 0.020 |
Why?
|
Antigens, Viral | 1 | 2009 | 1035 | 0.020 |
Why?
|
Amoxicillin | 1 | 2005 | 170 | 0.020 |
Why?
|
Cephalosporins | 1 | 2005 | 204 | 0.020 |
Why?
|
Azithromycin | 1 | 2005 | 196 | 0.010 |
Why?
|
Telemedicine | 1 | 2021 | 2872 | 0.010 |
Why?
|
Mass Screening | 1 | 2019 | 5255 | 0.010 |
Why?
|
Candidiasis | 1 | 2005 | 366 | 0.010 |
Why?
|
Mutation | 1 | 2007 | 29786 | 0.010 |
Why?
|
Genomics | 1 | 2018 | 5720 | 0.010 |
Why?
|
Program Evaluation | 1 | 2010 | 2488 | 0.010 |
Why?
|
Animals | 2 | 2007 | 168757 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 13695 | 0.010 |
Why?
|
Infant, Premature | 1 | 2006 | 2044 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2010 | 5317 | 0.010 |
Why?
|
Acute Disease | 1 | 2005 | 7149 | 0.010 |
Why?
|
Primary Health Care | 1 | 2010 | 4558 | 0.010 |
Why?
|
Drug Resistance | 1 | 2000 | 1609 | 0.010 |
Why?
|
Body Weight | 1 | 2000 | 4669 | 0.010 |
Why?
|
Concepts
(284)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(12)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_